Literature DB >> 15773042

A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans.

Ronen Spiegel1, Gideon Bach, Vivi Sury, Getu Mengistu, Bela Meidan, Stavit Shalev, Yona Shneor, Hanna Mandel, Marsha Zeigler.   

Abstract

A six-month-old infant girl presenting with progressive encephalopathy and abnormal myelination in the cerebral white matter was originally diagnosed as suffering from Krabbe disease. The diagnosis was based on a deficiency of galactocerebrosidase activity found in leukocytes isolated from whole blood. When cultured skin fibroblasts did not show a similar enzyme deficiency and sulphatide (stearoyl-1-14C) uptake indicated an abnormal storage of galactosylceramide, a deficiency of an activator was implied. A three base pair deletion was found in the saposin A coding sequence of the prosaposin gene leading to the deletion of a conserved valine at amino acid number 11 of the saposin A protein. This deletion in saposin A is proposed as the cause for the abnormal galactosylceramide metabolism in this infant. This is the first report of a saposin A mutation in humans leading to pathological consequences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773042     DOI: 10.1016/j.ymgme.2004.10.004

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  39 in total

1.  Structure of saposin A lipoprotein discs.

Authors:  Konstantin Popovic; John Holyoake; Régis Pomès; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

2.  Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31.

Authors:  Geneviève Bernard; Isabelle Thiffault; Martine Tetreault; Maria Lisa Putorti; Isabelle Bouchard; Michel Sylvain; Serge Melançon; Rachel Laframboise; Pierre Langevin; Jean-Pierre Bouchard; Michel Vanasse; Adeline Vanderver; Guillaume Sébire; Bernard Brais
Journal:  Neurogenetics       Date:  2010-07-17       Impact factor: 2.660

Review 3.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

4.  Lysosomal storage diseases: heterogeneous group of disorders.

Authors:  David A Wenger; Paola Luzi; Mohammad A Rafi
Journal:  Bioimpacts       Date:  2013-12-02

Review 5.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

Review 6.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

Review 7.  Invertebrate models of lysosomal storage disease: what have we learned so far?

Authors:  Samantha Hindle; Sarita Hebbar; Sean T Sweeney
Journal:  Invert Neurosci       Date:  2011-10-25

8.  Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.

Authors:  Clarissa Valdez; Daniel Ysselstein; Tiffany J Young; Jianbin Zheng; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 9.  Properties, metabolism and roles of sulfogalactosylglycerolipid in male reproduction.

Authors:  Nongnuj Tanphaichitr; Kessiri Kongmanas; Kym F Faull; Julian Whitelegge; Federica Compostella; Naoko Goto-Inoue; James-Jules Linton; Brendon Doyle; Richard Oko; Hongbin Xu; Luigi Panza; Arpornrad Saewu
Journal:  Prog Lipid Res       Date:  2018-08-25       Impact factor: 16.195

10.  Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.

Authors:  Ying Sun; Matt Zamzow; Huimin Ran; Wujuan Zhang; Brian Quinn; Sonya Barnes; David P Witte; Kenneth D R Setchell; Michael T Williams; Charles V Vorhees; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.